• 1. Aerobic oxidative synthesis of quinazolinones and benzothiazoles in the presence of laccase/DDQ as a bioinspired cooperative catalytic system under mild conditions
  Nadia Ghorashi,Zahra Shokri,Reza Moradi,Amira Abdelrasoul,Amin Rostami RSC Adv. 2020 10 14254

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Introduction to 4-(1,3-Benzothiazol-2-yl)benzaldehyde (CAS No. 2182-80-1) and Its Applications in Modern Chemical Biology

4-(1,3-Benzothiazol-2-yl)benzaldehyde, identified by the chemical abstracts service number 2182-80-1, is a heterocyclic aromatic aldehyde that has garnered significant attention in the field of chemical biology due to its versatile structural properties and potential biological activities. This compound belongs to the benzothiazole family, a class of molecules widely studied for their pharmacological significance. The benzothiazole core is a fused system consisting of a benzene ring and a thiazole ring, which together contribute to the unique electronic and steric characteristics of this molecule. These features make 4-(1,3-Benzothiazol-2-yl)benzaldehyde a valuable scaffold for the development of novel therapeutic agents.

The structural motif of 4-(1,3-Benzothiazol-2-yl)benzaldehyde incorporates a formyl group at the 2-position of the benzothiazole ring, which is a key functional moiety that enables various chemical transformations. This formyl group can participate in condensation reactions, forming Schiff bases, or undergo oxidation to yield corresponding carboxylic acids. Such reactivity has been exploited in synthetic chemistry to generate derivatives with enhanced biological properties. The presence of the benzene ring adjacent to the benzothiazole moiety further enhances the compound's potential for interactions with biological targets, making it an attractive candidate for drug discovery.

In recent years, there has been a surge in research focusing on benzothiazole derivatives due to their demonstrated efficacy in various therapeutic areas. Studies have highlighted the antimicrobial, anti-inflammatory, and anticancer properties of compounds containing the benzothiazole scaffold. Specifically, 4-(1,3-Benzothiazol-2-yl)benzaldehyde has been investigated for its potential role in modulating biological pathways associated with these diseases. For instance, research has shown that this compound can interact with enzymes and receptors involved in cancer cell proliferation and apoptosis. The exact mechanisms by which it exerts these effects are still under investigation but preliminary findings suggest that its ability to disrupt key signaling pathways may contribute to its therapeutic potential.

The synthesis of 4-(1,3-Benzothiazol-2-yl)benzaldehyde can be achieved through several routes, each offering distinct advantages depending on the desired scale and purity requirements. One common approach involves the condensation of 2-aminothiophenol with malonaldehyde in the presence of an acid catalyst, followed by cyclization and formylation. Alternatively, palladium-catalyzed cross-coupling reactions have been employed to construct the benzothiazole core from more readily available precursors. These synthetic strategies highlight the compound's accessibility and versatility for further derivatization.

From a computational chemistry perspective, 4-(1,3-Benzothiazol-2-yl)benzaldehyde has been subjected to molecular modeling studies to predict its binding interactions with biological targets. These studies have provided insights into how the compound might dock into enzyme active sites or receptor binding pockets. For example, simulations have suggested that the formyl group and the benzothiazole moiety can form hydrogen bonds and hydrophobic interactions with key residues in target proteins. Such information is crucial for rational drug design and optimizing lead compounds for clinical development.

The pharmacological profile of 4-(1,3-Benzothiazol-2-yl)benzaldehyde has been further explored through in vitro assays. Initial studies have demonstrated its ability to inhibit certain enzymes implicated in inflammatory responses. The compound's structure allows it to mimic natural substrates or modulate enzyme activity indirectly by altering conformational dynamics. Additionally, its interaction with membrane-bound receptors has been investigated as a potential mechanism for its biological effects. These findings underscore the compound's multifaceted pharmacological properties and its potential as a starting point for developing novel therapeutics.

Recent advances in biotechnology have enabled high-throughput screening methods that can rapidly assess the activity of compounds like 4-(1,3-Benzothiazol-2-yl)benzaldehyde against large libraries of biological targets. Such screens have identified novel applications for this molecule in areas beyond traditional medicine. For example, there is growing interest in using benzothiazole derivatives as scaffolds for developing antimicrobial agents against drug-resistant pathogens. The unique structural features of 4-(1,3-Benzothiazol-2-yl)benzaldehyde make it well-suited for addressing this critical challenge.

The environmental impact of synthesizing and using 4-(1,3-Benzothiazol-2-yl)benzaldehyde is also an important consideration in modern chemical biology research. Efforts are being made to develop greener synthetic routes that minimize waste and reduce energy consumption. Catalytic methods and solvent-free reactions are being explored as alternatives to traditional approaches. These innovations not only improve sustainability but also enhance scalability for industrial applications.

In conclusion,4-(1,3-Benzothiazol-2-yl)benzaldehyde (CAS No. 2182-80-1) represents a promising compound with significant potential in pharmaceutical research and development. Its unique structural features and versatile reactivity make it an ideal candidate for generating novel bioactive molecules. As our understanding of biological systems continues to evolve,4-(1,3-Benzothiazol-2-y]benzaldehyde will likely play an increasingly important role in addressing some of today's most pressing medical challenges.

• 16112-21-3(2-(4-methylphenyl)-1,3-benzothiazole)
• 10205-58-0(6-Methyl-2-phenyl-1,3-benzothiazole)
• 127868-63-7(Benzaldehyde,3-(2-benzothiazolyl)-)
• 1211-32-1(2-(3-Methylphenyl)-1,3-benzothiazole)
• 883-93-2(2-Phenylbenzothiazole)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)